{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:58:16Z","timestamp":1776196696135,"version":"3.50.1"},"reference-count":23,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/0971-4065.179301","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T12:13:43Z","timestamp":1483618423000},"page":"44","source":"Crossref","is-referenced-by-count":7,"title":["Study of anemia in nondialysis dependent chronic kidney disease with special reference to serum hepcidin"],"prefix":"10.25259","volume":"27","author":[{"given":"H","family":"Goyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Rani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.179301-1","first-page":"260","volume-title":"Chronic kidney disease: Global dimension and perspectives","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"key-10.4103\/0971-4065.179301-2","first-page":"292","volume-title":"Efficacy and safety of continuous erythropoietin receptor activator (CERA)","author":"Aggawal","year":"2011","journal-title":"Int J Pharm Pharm Sci"},{"key":"key-10.4103\/0971-4065.179301-3","unstructured":"Bargman JM, Skorecki K. Chronic kidney disease. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 18th ed. New York: The McGraw Hill Companies, Inc.; 2012."},{"key":"key-10.4103\/0971-4065.179301-4","first-page":"i18","volume-title":"Inflammation and its impact on anaemia in chronic kidney disease: From haemoglobin variability to hyporesponsiveness","author":"De","year":"2009","journal-title":"NDT Plus"},{"key":"key-10.4103\/0971-4065.179301-5","first-page":"53","volume-title":"Clinical factors influencing sensitivity and response to epoetin","author":"Richardson","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.179301-6","first-page":"1384","volume-title":"Hepcidin for clinicians","author":"Young","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.179301-7","first-page":"1076","volume-title":"Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: A cross-sectional study","author":"Uehata","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.179301-8","doi-asserted-by":"crossref","unstructured":"Kemna EH, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: From discovery to differential diagnosis. Haematologica 2008;93:90-7.","DOI":"10.3324\/haematol.11705"},{"key":"key-10.4103\/0971-4065.179301-9","first-page":"2090","volume-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"key-10.4103\/0971-4065.179301-10","first-page":"394","volume-title":"Molecular control of iron transport","author":"Ganz","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.179301-11","first-page":"1271","volume-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0971-4065.179301-12","first-page":"7811","volume-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","author":"Pigeon","year":"2001","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0971-4065.179301-13","first-page":"3730","volume-title":"Suppression of hepcidin during anemia requires erythropoietic activity","author":"Pak","year":"2006","journal-title":"Blood"},{"key":"key-10.4103\/0971-4065.179301-14","first-page":"e99781","volume-title":"The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease","author":"Mercadal","year":"2014","journal-title":"PLoS One"},{"key":"key-10.4103\/0971-4065.179301-15","first-page":"S1","volume-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification","author":"National","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.179301-16","first-page":"279","volume-title":"KDIGO clinical practice guideline for anemia in chronic kidney disease","author":"Kidney","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"key-10.4103\/0971-4065.179301-17","first-page":"S11","volume-title":"KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","author":"KDOQI;","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.179301-18","first-page":"848","volume-title":"Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate","author":"Peters","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.179301-19","first-page":"976","volume-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease","author":"Ashby","year":"2009","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.179301-20","first-page":"1051","volume-title":"Hepcidin \u2013 A potential novel biomarker for iron status in chronic kidney disease","author":"Zaritsky","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.179301-21","first-page":"1681","volume-title":"Current status of the measurement of blood hepcidin levels in chronic kidney disease","author":"Macdougall","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.179301-22","first-page":"1748","volume-title":"Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: Need for standardization","author":"Kroot","year":"2009","journal-title":"Haematologica"},{"key":"key-10.4103\/0971-4065.179301-23","first-page":"769","volume-title":"Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients","author":"Ford","year":"2010","journal-title":"Kidney Int"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:40:28Z","timestamp":1712173228000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/study-of-anemia-in-nondialysis-dependent-chronic-kidney-disease-with-special-reference-to-serum-hepcidin\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"alternative-id":["179301"],"URL":"https:\/\/doi.org\/10.4103\/0971-4065.179301","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}